{
  "docId": "019de50e-d292-716f-9ce2-d72fb83a57c0",
  "docSlug": "bede1f03edbb16951b81551a4f6eebab",
  "documentTitle": "Theranos | Investor Conference Presentation Deck | 88 slides",
  "authorId": "theranos",
  "authorName": "Theranos",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2016-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 85,
  "pageCount": 88,
  "prevPage": 84,
  "nextPage": 86,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de50e-d292-716f-9ce2-d72fb83a57c0/85",
  "deckHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0",
  "deckJsonHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0.json",
  "deckAnchorHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0#slide-85",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.49,
        "x": 0.036,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "This technology has not been cleared or approved by the FDA and is not for sale in the United States.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "04386889-a240-46c4-8b5c-ea522cf89bbb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.92,
        "x": 0.036,
        "y": 0.23
      },
      "kind": "table",
      "text": "Population: Healthy or Zika symptomatic; Sample type and matrix: Capillary whole blood, venous serum, and urine; Analyzers & assays: 20 miniLabs, CDC RT-PCR assay, altona RealStar (EUA Authorized Method); Study design: FDA EUA guidance; Analysis: Compute negative and positive percent agreement compared to the comparative methods",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22d49407-cf37-4217-b702-b061a420c75e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.63,
        "x": 0.036,
        "y": 0.125
      },
      "kind": "title",
      "text": "NAA Zika Assay: Clinical Study Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44de38cc-b636-440c-bbc9-c7d17198f612",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "6b423ae5-ed0d-48c5-ae98-73b07a9d3568",
      "evidence": "table/data: Population: Healthy or Zika symptomatic; Sample type and matrix: Capillary whole blood, venous serum, and urine; Analyzers & assays: 20 miniLabs, CDC RT-PCR assay, altona RealStar (EUA Authorized Method); Stu",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 88,
      "from": 79,
      "beatId": "c92ac2b4-6a5d-4b5e-bb35-0f9efe51a074",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Conclusion",
      "beatSlug": null,
      "evidence": "The document concludes with a summary of the key points and takeaways",
      "position": 5,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}